Although, the number of signaling pathways are deregulated in malignancies, however; besides being invariably activated in hematological malignancies, JAK/STAT signaling is, altered in many solid tumors and showed deregulated activation (Joshi et al., 2015). The gene discussed is SOAT1; the disease is cancer.